Synthesized Peptide Complex Biologically Active Food Supplement
Vesugen Synthesized Blood Vessels Peptide 60 Capsules
Normalizes the function of the blood vessels
Reducing peptide deficiency
Restoring protein synthesis inside cells
Vesugen - Synthesized Blood Vessels Peptide
Vesugen is a dietary supplement with а synthesized peptide of the vascular system. It normalizes the function of the blood vessels by reducing their peptide deficiency and restoring protein synthesis inside their cells.
Vesugen is recommended for everyone whose blood circulation may be compromised, especially elderly people and those with vascular disease, microcirculatory disturbances in different organs and tissues, atherosclerosis, coronary heart disease, hypertension, hypertonia, encephalopathy, vegetative-vascular dystonia, hypercholesterolemia or varicose veins.
Vesugen can be easily combined with other supplements and medicines and should be used in addition to conventional medical treatments. Biologically active food supplement Vesugen is a peptide complex containing the following amino acids: lysine, glutamine and asparagine, normalizing vascular system functions.
Vesugen is manufactured in the form of tablets or capsules with 0.100 mg content of an active substance. Experimental studies in the vascular organotypic tissue culture have shown, that the peptide complex is capable of stimulating proliferative and functional activity of the main cellular elements of the vascular wall tissue culture, as well as reducing spontaneous cell death rate, enhancing regenerative-adaptive processes in proliferating and differentiating cells. The substance exerts a trophic and stabilizing effect on morphological status and tissue regeneration in the vascular wall, thus improving its function. Pre-clinical experiments in vivo showed that Vesugen possesses a tissue-specific activity with respect to vascular wall cells, improves their trophics and regulates their metabolism, facilitates the normalization of functional and morphological changes in vascular wall, regulates blood cholesterol/lipoprotein level, thus decreasing the risk of different vessel damages. Based on the above, the effective application of Vesugen for restoration of blood vessel functions disordered in the course of different diseases, including atherosclerosis, is anticipated. Atherosclerosis and its consequences are considered to be one of the leading causes of incapacitation and deaths in developed countries. Changes in the vascular wall, accumulated with age and, as a result, hemodynamic disturbances lead to the decreased peripheral blood circulation, vascularization of tissues and organs, development of components of oxygen deficiency and trophic disorders in different tissues and organs. Vesugen clinical trials enrolled 87 patients with vascular atherosclerosis. Fifty three patients in the main group (33 men and 20 women) received Vesugen per os, 1-2 capsules with food 1-2 times a day for 20-30 days, in addition to commonly used medications, depending on the intensity of pathological process. Thirty four patients (18 men and 16 women) in the control group were prescribed only conventional remedies. Patients of both groups aged from 50 to 82 years.
Both groups of patients reported different clinical manifestations of atherosclerosis, depending on severity of damage of various vessels, such as essential hypertension; ischemic disease associated with coronary artery damage; cerebrovascular disorders with memory impairment, concentration deficiency, affective lability of patients with cerebral atherosclerosis. Disease progression was diagnosed in all patients. Earlier, all subjects under study used to get symptomatic and pathogenetic treatment on the account of specific clinical manifestations of vascular pathology.
Patients’ complaints, clinical blood and urine tests, biochemical blood study results were evaluated in dynamics. Blood coagulogram was performed and Hess test with tourniquet was applied to examine homeostasis.
It was registered that the administration of Vesugen to patients with arterial atherosclerosis improved their general status, normalized the sleep, especially in patients with cerebrovascular disorders. Patients with ischemic disease pointed out decreased arrhythmia manifestations and stenocardia attacks. Patients with essential hypertension associated normalization of blood pressure with Vesugen administration in combination with antihypertensive agents. They were able to achieve a long-lasting remission between hypertension attacks by using lower doses of conventional antihypertensive drugs.
As shown below (Table 2), Vesugen administration provided for a decrease in general cholesterol level in the blood.
A tendency to the decrease in the content of extra-low density lipoproteids, known to be the most atherogenic, has also been revealed in the course of the trial. Therefore, the results of clinical study confirm Vesugen therapeutic effect and expediency of its application in the complex therapy of vascular atherosclerosis. Since no side effects, complications, contraindications or drug addiction have been revealed, Vesugen is considered to be suitable for per os application. As a biologically active food supplement, Vesugen may be employed for therapeutic and prophylactic purposes in complex therapy of patients with vascular atherosclerosis. It also appeared useful for the improvement of microcirculation in combination with other means of symptomatic and pathogenetic therapy in case of different tissues.
Blood Vessels Synthesized Peptide Vesugen 60 Capsules
For many years the peptide preparations were available only as medicines, in the form of injections. However some years ago Prof. Khavinson and the Russian St. Petersburg Institute of Bioregulation and Gerontology created dietary supplements that can also reduce peptide deficiency and restore peptide-protein cycle in cells. They can be divided into natural (Cytomaxes) and synthesized (Cytogens) russian peptide bioregulators.
Natural russian peptide bioregulators (Cytomaxes)
Natural russian peptide bioregulators is a group of peptides of less than 50 amino acids and with a molecular mass of less than 5 kDa, free from foreign DNA or protein substance, extracted from organs and tissues of young calves by a patented method of thorough filtering. 5 kDa is very little. The molecular mass of DNA fragments and proteinaceous infectious particles, the prions, are several times bigger than that. Therefore these natural russian peptide supplements are extremely clean products. They do not have any immunogenic or mutagenic properties.
Inside the gastrointestinal tract the natural russian peptide bioregulators break down into amino acids and di-, tri- and tetrapeptides that match the DNA in a complementary way and activate protein synthesis in the respective body system. Their performance is gentle and gradual. Their effect continues to grow even after finishing the supplementation course and lasts up to 4-6 months until the peptide-protein cycle is impaired again.
Synthesized peptide bioregulators (Cytogens)
The analysis of natural peptides was used to detect the most active peptide from a group, which was later replicated in a lab. Synthesized (Cytogens) peptide bioregulators supplement contains only one peptide molecule whereas natural one includes a group of molecules. Synthesized peptides have an immediate impact compared to natural peptides and have a faster, yet more short-lived effect (1.5-2 months). Such peptides are typically used to start the initial peptide deficiency treatment. However, it is advised to switch to natural (Cytomaxes) peptides as a follow-up course.
Both types of peptides are efficient, safe to use, have no side effects and are compatible among themselves and with other products. As for the choice between natural and synthesized russian peptides, it depends on a particular situation. However, in most cases synthesized peptides, if available, are administered prior to the use of natural peptides.
Buy Russian synthesized peptide bioregulators online from MHC an official distributor in the US.
Ingredients (per 1 capsule): peptide AC-2 (lysine, glutamic acid, aspartic acid). Inactive ingredients: microcrystalline cellulose (E460), beetroot sugar, lactose, starch, Tween-80.
Contraindications: an individual tolerance of components, pregnancy, lactation
Recommendations for application: adults take 1-2 capsules. 1-2 times a day during meals.
Receiving duration: one month +, repeat every 4-6 months.
INTRODUCTION TO SYNTHETIC PEPTIDES
The Saint Petersburg Institute of Bioregulation and Gerontology (SPIBG) of the North-Western Branch of the Russian Academy of Medical Sciences for years has been developing a special approach to a new class of peptide-based supplements. As a result of the analysis of the amino-acidic sequence of peptides extracted from organs and tissues, physiologically active short peptides have been developed and later defined as a class of cytogenes, also known as the synthesized short peptides. This class of dietary supplements is characterized by a faster action compared to extracts: the physiological effects become evident after 24 hours, the main processes related to regulating work and functionality of organs and systems are launched. It is therefore considered highly important to take these synthetic peptides in the earliest stage of biotherapy.
On the other hand, the extracted peptides, widely known as the cytomax class, or the natural peptides, perform in a more delicate and gradual manner due to their so called specific physiological environment: it includes amino acids and microelements typical for that type of tissue from which they have been extracted in terms of quantity and quality. As a consequence of discrepancy in performance and effects of the different classes of peptides (synthesized or natural), SPIBG recommends their step-wise use as more reasonable. For instance, in the first four weeks a course of synthetic peptides can be taken, followed by one to two months of biotherapy based on natural peptides.
Synthesized Peptides Combinations
• Digestive system: OVAGEN VESUGEN CRYSTAGEN
• Vascular system: VESUGEN CRYSTAGEN
• Central nervous system: PINEALON VESUGEN OVAGEN
• Respiratory system: CHONLUTEN CRYSTAGEN VESUGEN
• Immune system: CRYSTAGEN VESUGEN OVAGEN
• Locomotor apparatus: CARTALAX VESUGEN CRYSTAGEN
• Adverse factors (radio - and chemotherapy, long-term ionizing irradiation, psychoemotional stress): VESUGEN OVAGEN CHONLUTEN
Please note: You should always consult a primary care physician/health practitioner of choice when considering the use of any products for health purposes, especially when undergoing treatment for an existing condition.